Related references
Note: Only part of the references are listed.In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii
X. Vila-Farres et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
In Vivo Efficacy of Glycopeptide-Colistin Combination Therapies in a Galleria mellonella Model of Acinetobacter baumannii Infection
M. Hornsey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
Madhuri M. Sopirala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
N. C. Gordon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea. emergence of a novel OXA-182
Chang-Ki Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea
Young Kyoung Park et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
The detection of synergy between meropenem. and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay
George A. Pankey et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals
Young Kyoung Park et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea
Jae-Hoon Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Extreme Drug Resistance in Acinetobacter baumannii Infections in Intensive Care Units, South Korea
Young Kyoung Park et al.
EMERGING INFECTIOUS DISEASES (2009)
Extensively Drug-Resistant Acinetobacter baumannii
Yohei Doi et al.
EMERGING INFECTIOUS DISEASES (2009)
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy
Ellen S. Moland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii
Alessandro Capone et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Current concepts: Acinetobacter infection
L. Silvia Munoz-Price et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy
Joshua S. Hawley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases
Marie-Francoise Tripodi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
An increasing threat in hospitals:: multidrug-resistant Acinetobacter baumannii
Lenie Dijkshoorn et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates
Thean Yen Tan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
Joon Young Song et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumanni
Marc H. Scheetz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Roxanne J. Owen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Anton Y. Peleg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam
Maria E. Pachon-Ibanez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Share Paper
